Letter of Medical Necessity Template and Prior Authorization Appeal Checklist

A Letter of Medical Necessity (LMN) template—and its closely related counterpart, the prior authorization appeal letter—is a structured clinical justification signed by a treating physician or advanced practice provider to substantiate that a requested procedure, medication, diagnostic test, or medical device is clinically necessary for a specific patient. While an initial sample letter of medical necessity often accompanies a baseline durable medical equipment (DME) or specialty pharmacy order, an appellate LMN is drafted to overturn an adverse benefit determination (such as an X12 835 Claim Adjustment Reason Code CARC 50 denial) during pre-service prior authorization or post-service claim review.

Purpose and Clinical Setting

Health plans, pharmacy benefit managers (PBMs), and Medicare Administrative Contractors (MACs) evaluate medical necessity requests against codified clinical criteria—including Medicare National Coverage Determinations (NCDs), Local Coverage Determinations (LCDs), commercial medical policies, or third-party InterQual criteria and Milliman Care Guidelines (MCG). An LMN or medical necessity appeal letter fails when it states only a clinician’s general preference; it succeeds when it maps contemporaneous progress-note evidence point-by-point to each criterion in the payer’s denial notice.

Checklist Table: Required Components of a Medical Necessity Appeal Packet

Before submitting a prior authorization appeal or LMN, clinical documentation and revenue-cycle teams verify six mandatory evidence categories:

Category	Required Item	Clinical & Regulatory Purpose	Documentation Notes
1. Administrative Identifiers	Patient name, DOB, member ID, claim/reference number, date of service, and denial code (e.g., CARC 50)	Links the appeal packet to the exact prior authorization tracking number or adjudicated X12 837/835 claim.	Include a copy of the payer’s original Adverse Benefit Determination notice.
2. Coding Alignment	Primary and secondary ICD-10-CM diagnosis and CPT/HCPCS procedure or J-codes	Demonstrates that the billed diagnosis code is on the payer’s covered-indication crosswalk for the requested CPT/HCPCS code.	Verify highest diagnostic specificity (laterality, acuity, stage, and complications).
3. Objective Clinical Findings	Contemporaneous progress notes, imaging reports, pathology, lab panels, and validated severity scores	Substantiates disease severity under CMS 42 CFR Part 410 or commercial utilization review thresholds.	An LMN alone cannot substitute for missing facts in the underlying medical record; attach the dated chart notes.
4. Prior Therapy History	Chronological log of prior conservative or step therapy trials (drug/modality, dose, start/stop dates, clinical failure or contraindication)	Satisfies fail-first and conservative-management prerequisites (e.g., 6 weeks of physical therapy or first-line generic failure).	Specify objective metrics of treatment failure, intolerability, or clinical contraindication.
5. Policy & Literature Rebuttal	Direct citation to the payer’s Clinical Policy Bulletin (CPB), Medicare LCD/NCD, or specialty society guidelines	Addresses the specific exclusion reason (e.g., “not medically necessary” vs. “experimental/investigational”).	Attach 1–2 peer-reviewed Phase III trial publications or FDA-approved labeling if appealing an off-label or novel therapy denial.
6. Provider Attestation	Treating clinician’s signature, credentials, specialty board certification, NPI, and peer-to-peer contact number	Establishes clinical accountability and requests a specialty-matched reviewer under ERISA 29 CFR § 2560.503-1(h)(3)(iii).	State whether an expedited 72-hour review is required due to clinical urgency.

How to Write a Prior Authorization Appeal Letter (Copy-Ready Template)

Clinicians and research billing coordinators can adapt the structured template below when drafting an LMN or appealing a prior authorization denial. When using EHR smart phrases or an internal AI appeal letter generator inside a HIPAA-covered environment, verify that every date, lab value, and prior medication trial in the draft matches the signed electronic health record:

[DATE]

ATTN: Medical Appeals Department / Utilization Management Review
[PAYER NAME]
[PAYER APPEALS ADDRESS OR FAX NUMBER]

RE: LETTER OF MEDICAL NECESSITY / LEVEL [1 / 2] PRIOR AUTHORIZATION APPEAL
Patient Name: [PATIENT FULL NAME]          Date of Birth: [YYYY-MM-DD]
Member ID: [MEMBER ID]                     Claim / Auth Ref #: [REFERENCE NUMBER]
Requested Service / Medication / Device:   [NAME OF SERVICE/DRUG]
CPT / HCPCS Code(s): [CPT/HCPCS CODES]     ICD-10-CM Code(s): [ICD-10-CM CODES]
Date(s) of Service: [DATE OR UPCOMING]     Review Type: [ ] Standard  [ ] Expedited (72-Hr)

Dear Medical Director and Clinical Appeals Reviewer:

I am writing as the treating [SPECIALTY, e.g., Board-Certified Rheumatologist / Neurologist]
for [PATIENT NAME] to appeal the adverse determination dated [DENIAL DATE] denying
coverage for [REQUESTED SERVICE/MEDICATION] (CPT/HCPCS [CODE]) as "not medically
necessary" under [PAYER POLICY NUMBER / LCD ID]. Based on [PATIENT NAME]'s documented
clinical severity and prior treatment history, [REQUESTED SERVICE] is medically necessary
and satisfies the clinical criteria set forth in your policy.

1. CLINICAL HISTORY, DIAGNOSIS, AND OBJECTIVE SEVERITY
[PATIENT NAME] is a [AGE]-year-old patient diagnosed with [PRIMARY DIAGNOSIS] (ICD-10-CM:
[CODE]) on [DATE]. Objective diagnostic findings documented in the attached clinical
progress notes dated [CHART NOTE DATES] include:
  - Diagnostic Imaging / Pathology / Labs: [SPECIFY RESULTS, DATES, AND VALUES]
  - Functional / Clinical Severity Score: [SPECIFY VALIDATED SCALE & BASELINE SCORE]

2. CHRONOLOGICAL SUMMARY OF FAILED CONSERVATIVE / STEP THERAPIES
Prior to requesting [REQUESTED SERVICE/DRUG], the patient completed or had documented
clinical contraindications to the following standard therapies required under [POLICY #]:
  - [THERAPY / DRUG 1, DOSE]: [START DATE] to [END DATE] — Outcome: [DOCUMENTED FAILURE,
    DISEASE PROGRESSION, OR ADVERSE EFFECT]
  - [THERAPY / DRUG 2, DOSE]: [START DATE] to [END DATE] — Outcome: [DOCUMENTED FAILURE
    OR CLINICAL CONTRAINDICATION]

3. POINT-BY-POINT ALIGNMENT WITH PAYER MEDICAL POLICY & CLINICAL GUIDELINES
Your denial letter states that [QUOTE EXACT DENIAL REASON]. However, as documented on
page [X] of the attached medical record:
  - Criterion A ([STATE CRITERION]): Met on [DATE] via [EVIDENCE FROM CHART].
  - Criterion B ([STATE CRITERION]): Met on [DATE] via [EVIDENCE FROM CHART].
Furthermore, current [SPECIALTY SOCIETY NAME] clinical practice guidelines recommend
[REQUESTED SERVICE] for patients presenting with this exact clinical phenotype.

4. REQUEST FOR SPECIALTY-MATCHED REVIEW AND REGULATORY DISCLOSURES
Without timely access to [REQUESTED SERVICE], [PATIENT NAME] faces an elevated risk of
[SPECIFIC CLINICAL COMPLICATION OR HOSPITALIZATION]. If this determination cannot be
overturned on initial review, I request a peer-to-peer review with a board-certified
physician in [SPECIALTY]. Pursuant to 29 CFR § 2560.503-1(g)-(h) (if an ERISA plan) or
applicable CMS regulations, please provide the specific internal clinical rationale and
the credentials/specialty of the reviewing clinician if an adverse decision is maintained.

Sincerely,

[PHYSICIAN SIGNATURE]
[PHYSICIAN NAME, MD/DO] | Specialty: [SPECIALTY] | NPI: [10-DIGIT NPI]
[FACILITY / INSTITUTION NAME] | Direct Phone: [PHONE] | Fax: [FAX]

Enclosures: (1) Denial Notice; (2) Signed Progress Notes ([DATES]); (3) Lab/Imaging
Reports; (4) Peer-Reviewed Clinical Guideline Excerpts.

What Varies by Payer Type: Commercial ERISA vs. Medicare Fee-for-Service vs. Medicare Advantage

• Private Employer-Sponsored Plans (ERISA, 29 CFR § 2560.503-1): Under federal Department of Labor regulations (29 CFR § 2560.503-1(g)(1)(v)), if an adverse benefit determination is based on medical necessity or an experimental/investigational exclusion, the plan must provide either an explanation of the scientific or clinical judgment for the determination or a statement that such explanation will be provided free of charge upon request. Under § 2560.503-1(h)(3), claimants have at least 180 days to file an administrative appeal, and the fiduciary must consult an independent healthcare professional with appropriate training and experience in the relevant field of medicine.
• Medicare Fee-for-Service (Social Security Act § 1862(a)(1)(A) & 42 CFR Part 405 Subpart I): Medicare Part A and Part B coverage requires services to be “reasonable and necessary for the diagnosis or treatment of illness or injury.” Post-service denials follow a five-level statutory appeal pathway beginning with a Level 1 Redetermination to the MAC (filed within 120 days of the Medicare Summary Notice or Remittance Advice) and a Level 2 Reconsideration to a Qualified Independent Contractor (QIC) (filed within 180 days).
• Medicare Advantage (Part C, 42 CFR §§ 422.101 & 422.566–590): Under CMS-4201-F rules, Medicare Advantage plans must follow traditional Medicare NCDs and LCDs when making medical necessity determinations and cannot apply internal proprietary criteria that are more restrictive than published Medicare coverage policies. Standard pre-service organization determination appeals must be decided within 30 calendar days (7 calendar days for Part B drugs), and expedited appeals within 72 hours.

Frequently Asked Questions

How do you write a prior authorization appeal letter or Letter of Medical Necessity?

To write an effective prior authorization appeal letter or Letter of Medical Necessity (LMN), match the patient’s contemporaneous medical record directly to the payer’s published clinical coverage policy, Local Coverage Determination (LCD), or utilization management criteria. Include patient identifiers, specific ICD-10-CM diagnosis codes and CPT/HCPCS procedure codes, objective diagnostic test and laboratory results, a chronological table of failed conservative or step-therapy treatments with dates and outcomes, peer-reviewed clinical guidelines supporting the requested service, and the rendering physician’s NPI and signature.

What federal rules govern medical necessity appeals under ERISA and Medicare?

For private employer-sponsored health plans, the ERISA Claims Procedure regulation (29 CFR § 2560.503-1) grants claimants at least 180 days to appeal an adverse benefit determination, mandates free disclosure of the internal clinical criteria used in the denial (§ 2560.503-1(g)(1)(v)), and requires review by a health care professional trained in the relevant medical specialty who was not involved in the initial denial (§ 2560.503-1(h)(3)). For traditional Medicare, Social Security Act § 1862(a)(1)(A) and 42 CFR Part 405 Subpart I govern reasonable-and-necessary determinations and the five-level administrative appeal process.

Sources

• U.S. Department of Labor — Employee Benefits Security Administration (EBSA): ERISA Claims Procedure Regulation, 29 CFR § 2560.503-1 (ecfr.gov).
• Centers for Medicare & Medicaid Services (CMS) — Medicare Fee-for-Service Appeals (42 CFR Part 405, Subpart I) and Medicare Advantage Organization Determinations (42 CFR Part 422, Subpart M) (ecfr.gov).